IXICO (PHYOF) Beginning Cash Position: $4.72 Mil (As of Mar. 2026)


PHYOF IXICO PLC PHYOF
42 GF Score
Price $0.07
GF Value $0.06
! 2 Warning Signs
View Full Analysis

What is IXICO Beginning Cash Position?

IXICO PHYOF -53.33% 42 Beginning Cash Position is $4.72 Mil as of Mar. 2026. GuruFocus rates PHYOF with a GF Score™ of 42/100 and a GF Value™ of $0.06. The stock has 2 warning signs investors should review.

IXICO's Beginning Cash Position for the quarter that ended in Mar. 2026 was $4.72 Mil.

IXICO's quarterly Beginning Cash Position increased from Mar. 2025 ($2.31 Mil) to Sep. 2025 ($6.77 Mil) but then declined from Sep. 2025 ($6.77 Mil) to Mar. 2026 ($4.72 Mil).

IXICO's annual Beginning Cash Position declined from Sep. 2023 ($7.14 Mil) to Sep. 2024 ($5.33 Mil) and declined from Sep. 2024 ($5.33 Mil) to Sep. 2025 ($2.42 Mil).

IXICO Beginning Cash Position Related Terms

IXICO Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for IXICO's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IXICO Beginning Cash Position Chart

IXICO Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.91 7.57 7.14 5.33 2.42

IXICO Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.12 3.35 2.31 6.77 4.72
PHYOF
42GF Score
IXICO PLC PHYOF
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IXICO Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $4.72 Mil mean?
IXICO (PHYOF) has a Beginning Cash Position of $4.72 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on IXICO and its competitors.
Is IXICO's Beginning Cash Position too high?
IXICO's current Beginning Cash Position is $4.72 Mil. Overall, IXICO has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does IXICO's Beginning Cash Position compare to VRTX and REGN?
IXICO's Beginning Cash Position of $4.72 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on IXICO and its competitors. IXICO's current Beginning Cash Position is $4.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IXICO stock overvalued right now?
IXICO (PHYOF) has a current Beginning Cash Position of $4.72 Mil. The stock's GF Value™ is $0.06, compared to a current price of $0.07 — trading 16.7% above its estimated fair value. The current Beginning Cash Position is $4.72 Mil. IXICO's overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For IXICO (PHYOF), the current Beginning Cash Position is $4.72 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IXICO (PHYOF) Overvalued in 2026?

Based on GuruFocus' analysis, IXICO stock appears to be overvalued. The current stock price of $0.07 is trading 16.7% above its estimated GF Value™ of $0.06.

Key valuation signals for PHYOF:

  • Beginning Cash Position: $4.72 Mil
  • GF Value™: $0.06 vs. price of $0.07 (16.7% above fair value)
  • GF Score™: 42/100 with 2 warning signs

No single metric tells the full story. See the PHYOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IXICO Business Description

Other Exchanges IXI:UK
Address 15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
IXICO PLC provides neuroscience imaging and biomarker analytics services, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. It operates as an imaging contract research organization, supporting clinical trials for neurological disorders by processing and analyzing imaging data. Its platform is used to measure biomarkers associated with diseases such as Alzheimer's, Huntington's, and Parkinson's.
42GF Score

Get the complete analysis for PHYOF

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.07
Price
$0.06
GF Value